Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Science

• Publication date

  1991-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1990444PMID 1990444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

  1990cited by this paper

• Knowledge accumulation and vaccine innovation: lessons from polio and HIV/AIDS

  2010cites this paper
• Protection of MN-rgp 120-Immunized Chimpanzees from Heterologous Infection with a Primary Isolate of Human Immunodeficiency Virus Type 1

  2010cites this paper
• HIV-1 Transmission, Replication Fitness and Disease Progression

  2008cites this paper
• Stabilization of the biologically active conformation of the principal neutralizing determinant of HIV-1(IIIB) containing a cis-proline surrogate: 1H NMR and molecular modeling study.

  2006cites this paper
• Maternal HIV‐1 Antibody and Vertical Transmission in Subtype C Virus Infection

  2002cites this paper
• Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes.

  2002cites this paper
• Prospects for an HIV Vaccine: Conventional Approaches and DNA Immunization

  2002cites this paper
• Applications of artificial neural network in AIDS research and therapy.

  2002cites this paper
• Conformationally Restricted Synthetic AIDS Vaccine

  2001cites this paper
• La Neuroinmunopatogénesis del VIH

  2001cites this paper
• Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.

  1999cites this paper
• Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand.

  1999cites this paper
• Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.

  1998cites this paper
• Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein.

  1997cites this paper
• Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.

  1997influential citation
• NMR study of the peptide present in the principal neutralizing determinant (PND) of HIV-1 envelope glycoprotein gp120.

  1997cites this paper
• Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture.

  1996cites this paper
• Protecting HIV databases

  1995cites this paper
• Candidate AIDS vaccines.

  1995cites this paper
• Syncytium-Inducing and Non-Syncytium-Inducing Capacity of Human Immunodeficiency Virus Type 1 Subtypes Other Than B: Phenotypic and Genotypic Characteristics

  1994influential citation
• Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.

  1994cites this paper
• Vaccines against human immunodeficiency virus--progress and prospects.

  1993cites this paper
• V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability

  1993cites this paper
• Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera.

  1993cites this paper
• Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.

  1993cites this paper
• Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

  1992cites this paper
• Molecular and immunological aspects of parasitism

  1992cites this paper
• Molecular Epidemiology of HIV Transmission in a Dental Practice

  1992cites this paper
• Mother‐to‐child transmission of human immunodeficiency virus

  1991cites this paper
• Prediction of optimal peptide mixtures to induce broadly neutralizing antibodies to human immunodeficiency virus type 1.

  1991cites this paper
• The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion?

  1991cites this paper
• Identifying Antibodies to Conformational Epitopes on HIV-1 gpl 20 with Alpha-Helical Peptides

  year unknowncites this paper